L827-0213 Screening compound: 4-[5-(3-phenyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]morpholine

L827-0213 Screening compound: 4-[5-(3-phenyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]morpholine
L827-0213 Screening compound: 4-[5-(3-phenyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound L827-0213
4-[5-(3-phenyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L827-0213

Molecular Formula

C17H16N4O2 (C17 H16 N4 O2)

Compound Name

4-[5-(3-phenyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]morpholine

IUPAC name

4-[5-(3-phenyl-124-oxadiazol-5-yl)pyridin-2-yl]morpholine

SMILES

C(COCC1)N1c(cc1)ncc1-c1nc(-c2ccccc2)no1

InChI

InChI=1S/C17H16N4O2/c1-2-4-13(5-3-1)16-19-17(23-20-16)14-6-7-15(18-12-14)21-8-10-22-11-9-21/h1-7,12H,8-11H2

InChI Key

CLFFDBJCRKOFDX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27478164

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

308.34

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.558

Distribution Coefficient, logD

3.535

Water Solubility, LogSw

-3.32

Polar Surface Area

51.606

Acid Dissociation Constant (pKa)

24.57

Base Dissociation Constant (pKb)

6.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.50

L827-0213 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

Antiparasite Library (23996 compounds)

GPCR Targeted Library (31838 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Infections
  • Immune system
  • animal
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
Agro:
  • Agro
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with L827-0213 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L827-0213?
Check Price and Availability of L827-0213, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L827-0213 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L827-0213
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L827-0213
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L827-0213 available by request